Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: DGX

Quest Diagnostics Incorporated

Healthcare | Medical - Diagnostics & Research
$189.87 -6.41 (-3.26%) as of 2026-07-14 13:06 UTC
Market Cap$21.4B
EPS (TTM)$8.75

Quest Diagnostics Incorporated (NYSE: DGX) is a $21.4B medical - diagnostics & research company trading at $189.87 (−3.3% today) — 21.7× trailing earnings, yielding 1.65%. Figures from SEC EDGAR and market feeds; updated 2026-07-14 13:06 UTC.

52-Week Range
Low $187.50High $209.59

What Quest Diagnostics Incorporated does

Quest Diagnostics provides laboratory testing and diagnostic insights to multiple customers across the healthcare system, including physicians, hospitals, patients, health plans, and employers. The company operates through laboratories, patient service centers, and offices across the United States and selected international locations, serving a substantial portion of the American adult population annually.

Summarized from Quest Diagnostics Incorporated’s SEC filings · Read the filing ↗

Key facts
Quote
Price$189.87
Change (1D)-6.41 (-3.26%)
Market cap$21.4B
52-week range$187.50 – $209.59
Valuation
P/E (TTM)21.70×
EV/EBITDA12.60×
EPS (TTM)$8.75
Dividend yield1.65%
Price/book2.98×
Return on equity13.77%
Debt/equity0.79
Returns
52-week return+1.3%
Revenue, margins & earnings
FY2021 Net income: $2.00BFY2021 Taxes & interest: $386MFY2021 Operating costs: $8.41B$10.8BFY2021FY2022 Net income: $946MFY2022 Taxes & interest: $482MFY2022 Operating costs: $8.46B$9.88BFY2022FY2023 Net income: $854MFY2023 Taxes & interest: $408MFY2023 Operating costs: $7.99B$9.25BFY2023FY2024 Net income: $871MFY2024 Taxes & interest: $475MFY2024 Operating costs: $8.53B$9.87BFY2024FY2025 Net income: $992MFY2025 Taxes & interest: $564MFY2025 Operating costs: $9.48B$11.0BFY2025
  • Net income
  • Taxes & interest
  • Operating costs
Annual revenue; bands show net, operating margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-07-02
  • 2026-07-02WENTWORTH TIMOTHY CA144—
  • 2026-06-08KUPPUSAMY KARTHIKSVP, Clinical SolutionsM3,320$424.0K
  • 2026-06-08KUPPUSAMY KARTHIKSVP, Clinical SolutionsM4,827$588.0K
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC14,339,489$2.49B+0.6%
  • BlackRock, Inc.7,283,684$1.43B-23.0%
  • VANGUARD CAPITAL MANAGEMENT LLC7,145,672$1.40BNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Quest Diagnostics Incorporated do?

Quest Diagnostics provides laboratory testing and diagnostic insights to multiple customers across the healthcare system, including physicians, hospitals, patients, health plans, and employers.

What is DGX's valuation?

DGX trades at $189.87, 21.70× trailing earnings, 12.60× EV/EBITDA, as of 2026-07-14. It carries a 1.65% dividend yield.

When did DGX last file with the SEC?

Quest Diagnostics Incorporated's most recent SEC filing on record is a 8-K filed 2026-05-08. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 13:06 UTC. This page is also available as JSON at /api/data?ticker=DGX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for DGX and 3,500+ tickers.

Create a free account — keep DGX
For your agent
GET /api/data?ticker=DGX

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt